Jacobson Robert M, Agunwamba Amenah A, St Sauver Jennifer L, Finney Rutten Lila J
a Department of Pediatric and Adolescent Medicine, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery , Mayo Clinic , Rochester , MN , USA.
b Department of Health Sciences Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery , Mayo Clinic , Rochester , MN , USA.
Expert Rev Vaccines. 2016;15(2):257-69. doi: 10.1586/14760584.2016.1116947. Epub 2015 Nov 27.
The US is failing to make substantive progress toward improving rates of human papillomavirus vaccine uptake. While the Healthy People 2020 goal for human papillomavirus (HPV) vaccination is 80%, the three-dose completion rate in the US in 2014 for 13- to 17-year-old females is less than 40%, and the rate for males is just above 20%. Experts point to a number of reasons for the poor HPV vaccination rates including parental concerns about safety, necessity, and timing. However, the evidence refuting these concerns is substantial. Efforts focusing on education and communication have not shown promise, but several population health strategies have reminder/recall systems; practice-focused strategies targeting staff, clinicians, and parents; assessment and feedback activities; and school-based HPV vaccination programs.
美国在提高人乳头瘤病毒疫苗接种率方面未能取得实质性进展。虽然《健康人民2020》中人乳头瘤病毒(HPV)疫苗接种的目标是80%,但2014年美国13至17岁女性的三剂次全程接种率不到40%,男性的接种率刚超过20%。专家指出HPV疫苗接种率低的诸多原因,包括家长对安全性、必要性和接种时间的担忧。然而,反驳这些担忧的证据很充分。侧重于教育和沟通的努力未见成效,但一些人群健康策略有提醒/召回系统;针对工作人员、临床医生和家长的以实践为重点的策略;评估和反馈活动;以及基于学校的HPV疫苗接种计划。